NasdaqGM - Nasdaq Real Time Price USD
INVO Fertility, Inc. (IVF)
1.8000
-0.0800
(-4.26%)
At close: May 2 at 4:00:00 PM EDT
1.7600
-0.04
(-2.22%)
After hours: May 2 at 7:56:55 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,227.7880
3,020.5750
822.1960
4,160.1160
1,037.2860
Cost of Revenue
3,587.0970
1,934.4370
850.7700
145.0520
88.7600
Gross Profit
2,640.6910
1,086.1380
-28.5740
4,015.0640
948.5260
Operating Expense
8,298.8480
7,853.2930
10,597.9070
9,231.5880
6,463.4920
Operating Income
-5,658.1570
-6,767.1550
-10,626.4810
-5,216.5240
-5,514.9660
Net Non Operating Interest Income Expense
-1,006.5790
-925.9090
-59.1370
-1,261.7020
-2,832.3140
Other Income Expense
-748.2610
-313.7620
-204.0210
-171.9500
--
Pretax Income
-7,412.9970
-8,006.8260
-10,889.6390
-6,650.1760
-8,347.2800
Tax Provision
54.1300
27.7860
2.8720
4.7640
0.0360
Net Income Common Stockholders
-7,467.1270
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Diluted NI Available to Com Stockholders
-7,467.1270
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Basic EPS
-1.01
-5.13
-18.00
-12.60
-30.40
Diluted EPS
-1.01
-5.13
-18.00
-12.60
-30.40
Basic Average Shares
3,289.2840
1,565.9510
606.1300
531.6200
274.4860
Diluted Average Shares
3,289.2840
1,565.9510
606.1300
531.6200
274.4860
Total Operating Income as Reported
-5,658.1570
-6,767.1550
-10,626.4810
-5,216.5240
-5,514.9660
Total Expenses
11,885.9450
9,787.7300
11,448.6770
9,376.6400
6,552.2520
Net Income from Continuing & Discontinued Operation
-7,467.1270
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Normalized Income
-6,905.6906
-7,834.3533
-10,889.7752
-6,768.5222
-8,347.3160
Interest Income
7.7850
--
0.3080
3.6570
4.1900
Interest Expense
1,006.5790
925.9090
59.4450
1,265.3590
2,836.5040
Net Interest Income
-1,006.5790
-925.9090
-59.1370
-1,261.7020
-2,832.3140
EBIT
-6,406.4180
-7,080.9170
-10,830.1940
-5,384.8170
-5,510.7760
EBITDA
-5,577.0270
-6,880.0230
-10,752.8930
-5,218.7350
-5,476.2950
Reconciled Cost of Revenue
3,587.0970
1,934.4370
850.7700
145.0520
88.7600
Reconciled Depreciation
829.3910
200.8940
77.3010
166.0820
34.4810
Net Income from Continuing Operation Net Minority Interest
-7,467.1270
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Total Unusual Items Excluding Goodwill
-710.6790
-253.4920
-3.4630
155.5920
--
Total Unusual Items
-710.6790
-253.4920
-3.4630
155.5920
--
Normalized EBITDA
-4,866.3480
-6,626.5310
-10,749.4300
-5,374.3270
-5,476.2950
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-149.2426
-53.2333
-0.7272
42.0098
--
12/31/2020 - 11/2/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NAOV NanoVibronix, Inc.
4.3000
+10.97%
RSLS ReShape Lifesciences Inc.
0.4200
+23.89%
BJDX Bluejay Diagnostics, Inc.
1.9200
-7.25%
TIVC Tivic Health Systems, Inc.
4.4600
-0.67%
SSII SS Innovations International Inc. Common Stock
10.51
-2.73%
AMIX Autonomix Medical, Inc.
2.0000
-12.66%
KIDS OrthoPediatrics Corp.
21.40
+2.25%
TNON Tenon Medical, Inc.
1.1700
-0.85%
DHAI DIH Holding US, Inc.
0.1980
+2.75%
SERA Sera Prognostics, Inc.
2.9100
-0.68%